Heated Intraperitoneal Chemotherapy in Primary Ovarian Cancer Patients
Status:
Unknown status
Trial end date:
2020-12-15
Target enrollment:
Participant gender:
Summary
This study will evaluate the use of Heated Intraperitoneal Chemotherapy (HIPEC) for primary
treatment of ovarian cancer at the time of surgical debulking, to assess if intravenous (IV)
chemotherapy can be started within 42 days of HIPEC and cytoreduction. All patients will
receive cytoreductive surgery followed by a one-time closed HIPEC with cisplatin at 41-43
degrees Celsius for 90 minutes in the operating room. This is followed by 6 cycles of
intravenous carboplatin and paclitaxel on an outpatient basis.